Cell-mediated immune functions, measured by the lymphocyte proliferative response to phytohemagglutinin and IL-2 production, were found to be reduced in drug-free PDA patients compared with the HCs, but after treatment (combined psychotherapy and pharmacological approach) no significant differences were found in the two groups [265]. The gene discussed is IL2; the disease is Patent ductus arteriosus.